| Usefulness of low iodine diet in managing patients with differentiated thyroid cancer-initial results M Dobrenic, D Huic, M Zuvic, D Grosev, R Petrovic, T Samardzic Radiology and oncology 45 (3), 189-195, 2011 | 25 | 2011 |
| Parathyroid carcinoma in pregnancy M Baretić, HT Brzac, M Dobrenić, A Jakovčević World Journal of Clinical Cases: WJCC 2 (5), 151, 2014 | 13 | 2014 |
| F-18 FDG PET/CT in pulmonary artery sarcoma: clinical vignette S Hmelik, M Dobrenić, D Huić Nuclear medicine review 21 (1), 48-49, 2018 | 12 | 2018 |
| Substituting doxorubicin with etoposide in R-CHOP results in a regimen with similar efficacy for treatment of newly diagnosed elderly patients with B-large cell lymphoma (B-LCL) I Hude, S Basic-Kinda, I Radman, S Dotlic, M Kralik, M Vodanovic, ... HAEMATOLOGICA 102, 399-399, 2017 | 1 | 2017 |
| Low iodine diet in patients with differentiated thyroid cancer M Dobrenić 30th Annual Congress of the European Association of Nuclear Medicine-EANM17 …, 2017 | 1 | 2017 |
| Clinical outcome of patients with parathyroid gland carcinoma-single centre experience M Baretic, M Dobrenic, D Prgomet, I Pavlic-Renar Endocrine Abstracts 37, 2015 | 1 | 2015 |
| The most important clinical factors connected with the positive Ga-68-PSMA PET-CT scan in patients with biochemical recurrence of prostate cancer I Rogic, AT Golubic, M Dobrenic, M Zuvic, T Smitran, N Jukic, D Huic Annual Congress of the European Association of Nuclear Medicine, 492-493, 2022 | | 2022 |
| ACTH secreting neuroendocrine tumor arising from thymus with brachiocephalic vein infiltration S Fares, M Dobrenić, D Huić Annual Congress of the European Association of Nuclear Medicine, 673-674, 2022 | | 2022 |
| eBEACOPP for front-line treatment of patients with classical Hodgkin lymphoma (cHL) in the real world setting S Basic-Kinda, D Dujmovic, I Radman, M Moric Peric, I Hude, N Durakovic, ... 11th International Symposium on Hodgkin Lymphoma, 26-26, 2018 | | 2018 |
| THE SWITCH FROM ABVD TO eBEACOPP AS FRONT-LINE THERAPY FOR HIGH-RISK STAGE III-IV CLASSICAL HODGKIN LYMPHOMA PATIENTS RESULTS IN AN INVERSION OF EVENT-FREE SURVIVAL OF … I Aurer, S Basic-Kinda, D Dujmovic, I Radman, B Dreta, S Dotlic, ... HAEMATOLOGICA 101, 24-24, 2016 | | 2016 |
| The switch from ABVD to eBEACOPP as front-line therapy for high-risk patients stage III-IV Hodgkin lymphoma (CHL) patients results in an inversion of event-free survival (EFS … I Aurer, S Basic-Kinda, D Dujmovic, I Radman, B Dreta, S Dotlic, ... 10th International Symposium on Hodgkin Lymphoma, 24-24, 2016 | | 2016 |
| Sentinel Node Mapping with SPECT/CT in Breast Cancer A Mutvar, D Huic, G Horvatic-Herceg, M Dobrenic, M Trogrlic, D Grosev, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 40, S462-S462, 2013 | | 2013 |
| Sentinel Lymph Node Mapping with SPECT/CT A Mutvar, D Huic, D Grosev, M Trogrlic, M Rubic, M Dobrenic, A Sporcic, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 39, S478-S478, 2012 | | 2012 |
| P067 (0166) VERY LATE RELAPSES (VLRS) IN HODGKIN LYMPHOMA (HL) OCCURING≥ 5 YEARS AFTER INITIAL TREATMENT WITH CHEMOTHERAPY±RADIOTHERAPY (CT±RT): PATTERN OF RISK OVER 35 YEARS … S Basic-Kinda, D Dujmovic, I Radman, MM Peric, I Hude, N Durakovic, ... | | |
